SMS Lifesciences India Limited reported earnings results for the fourth quarter ended March 31, 2022. For the fourth quarter, the company reported sales was INR 956.64 million compared to INR 825.14 million a year ago. Revenue was INR 973.87 million compared to INR 837.9 million a year ago. Net income was INR 80.75 million compared to INR 50.54 million a year ago. Basic earnings per share from continuing operations was INR 26.71 compared to INR 16.72 a year ago.